食品伙伴網(wǎng)訊   據(jù)澳新食品標準局（FSANZ）消息，2019年7月22日，澳新食品標準局發(fā)布85-19號通告，其中1155號申請，申請批準在嬰兒配方食品與其他產品中使用 2'-O-巖藻糖基乳糖（2'-FL）與乳酸-N-新四糖（LNnT）。

 

　　部分原文報道如下：

 

　　Pursuant to section 31 of the Food Standards Australia New Zealand Act 1991 （FSANZ Act）， FSANZ now calls for submissions to assist FSANZ's consideration of the draft food regulatory measure it has prepared arising from an application made by Glycom A/S to permit the voluntary addition of 2′-O-fucosyllactose （2′-FL） alone or in combination with Lacto-N-neotetraose （LNnT）， produced by microbial fermentation, in infant formula products and formulated supplementary foods for young children. The purpose of the application is to permit the voluntary use of 2'-O-fucosyllactose （2'-FL） alone or in combination with Lacto-N-neotetraose （LNnT）， produced by microbial fermentation using genetically modified Escherichia coli （E.coli） strains, in infant formula products and formulated supplementary foods for young children （FSFYC）。

 

　　本文由食品伙伴網(wǎng)食品資訊中心編輯，供網(wǎng)友參考，歡迎轉載，轉載請注明出處！有任何疑問，請聯(lián)系news@foodmate.net。